Literature DB >> 19233329

Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease.

Faten N Aberra.   

Abstract

Entities:  

Year:  2009        PMID： 19233329     DOI： 10.1053/j.gastro.2009.02.036

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

1.  Cost-effectiveness of QuantiFERON testing before initiation of biological therapy in inflammatory bowel disease.

Authors:  Arun Swaminath; Nahid Bhadelia; Y Claire Wang
Journal:  Inflamm Bowel Dis       Date:  2013-10       Impact factor: 5.325

2.  Active tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin America.

Authors:  Flora Maria Lorenzo Fortes; Ney Boa Sorte; Victor D Mariano; Laíla D Andrade; Fernanda A Oliveira; Monique Ca Santos; Cláudia Ivanilda N Dos Santos; Catharina A Passos; Mila P Pacheco; Valdiana C Surlo; Neogélia P de Almeida; Jaciane Am Fontes; Andréa M Pimentel; Raquel Rocha; Genoile Oliveira Santana
Journal:  World J Gastroenterol       Date:  2020-11-28       Impact factor: 5.742

3.  Tuberculin skin testing in inflammatory bowel disease patients from an endemic area of Brazil.

Authors:  Ingrid Puig Cardoso; Neogelia Pereira de Almeida; Daniela Rosa Gotardo; Mauricio Cardeal; Genoile Oliveira Santana
Journal:  Braz J Infect Dis       Date:  2013-09-20       Impact factor: 3.257
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.